Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.33 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14424428 | 0.99 | SIGMAR1 (0.34) | ESR1ESR2DHFRSIGMAR1 | |
| SCHEMBL761406 | 0.98 | ESR1 (0.34) | ESR1ESR2DHFRSIGMAR1 | |
| SCHEMBL761299 | 0.91 | ENPP1 (0.38) | DHFRGPR84 | |
| SCHEMBL13333604 | 0.90 | ESR1 (0.36) | ESR1ESR2DHFRSIGMAR1ACHE | |
| SCHEMBL14489459 | 0.90 | ESR1 (0.36) | ESR1ESR2DHFRSIGMAR1ACHE | |
| SCHEMBL762137 | 0.90 | DHFR (0.34) | DHFRSIGMAR1 | |
| SCHEMBL15762753 | 0.89 | SIGMAR1 (0.37) | ESR1ESR2DHFRSIGMAR1ACHE | |
| SCHEMBL14516042 | 0.89 | SIGMAR1 (0.37) | ESR1ESR2DHFRSIGMAR1ACHE | |
| SCHEMBL762122 | 0.89 | CRHR1 (0.34) | DHFRSIGMAR1GPR84 | |
| SCHEMBL761302 | 0.87 | ENPP1 (0.38) | GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1902013-B1 | NOVEL ANTHRACENE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, AND ORGANIC ELECTRONIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEMICAL LTD (KR) | 2016-06-01 | — | — | EP | disclosed |
| US-8137823-B2 | Anthracene derivatives, process for preparation thereof, and organic electronic light emitting device using the same | LG CHEM, LTD. (KR) | 2012-03-20 | — | — | US | disclosed |
| US-20090079334-A1 | Novel Anthracene Derivatives, Process for Preparation Thereof, and Organic Electronic Light Emitting Device Using the Same | LG CHEM, LTD. (KR) | 2009-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090079334-A1 | Novel Anthracene Derivatives, Process for Preparation Thereof, and Organic Electronic Light Emitting Device Using the Same | XPOT, ALAD, APRT | ESR1 143/4885ESR2 1238/4885DHFR 3494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.